Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology.

Inwald, E C; Ortmann, O; Koller, M; Zeman, F; Hofstädter, F; Evert, M; Brockhoff, G; Klinkhammer-Schalke, M

Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology.

Inwald, E C; Ortmann, O; Koller, M; Zeman, F; Hofstädter, F; Evert, M; Brockhoff, G; Klinkhammer-Schalke, M.

Afiliação

Inwald EC; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany. elisabeth.inwald@klinik.uni-regensburg.de.
Ortmann O; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany.
Koller M; Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
Zeman F; Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
Hofstädter F; Tumor Center Regensburg, University of Regensburg, Regensburg, Germany.
Evert M; Institute of Pathology, University of Regensburg, Regensburg, Germany.
Brockhoff G; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany.
Klinkhammer-Schalke M; Tumor Center Regensburg, University of Regensburg, Regensburg, Germany.

Breast Cancer Res Treat ; 163(1): 119-130, 2017 May.

Article em En | MEDLINE | ID: mdl-28205042

Assuntos

Neoplasias da Mama/patologia; Neoplasias da Mama/terapia; Receptor ErbB-2/metabolismo; Idoso; Idoso de 80 Anos ou mais; Neoplasias da Mama/metabolismo; Quimioterapia Adjuvante; Feminino; Alemanha; Disparidades em Assistência à Saúde; Humanos; Programas de Rastreamento; Mastectomia; Pessoa de Meia-Idade; Prognóstico; Radioterapia Adjuvante; Análise de Sobrevida; Resultado do Tratamento

Palavras-chave

Breast cancer; Cancer registry; Elderly patients; Mammography screening; Overall survival; Tumor biological subtypes

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Problema de saúde: 1_acesso_equitativo_servicos / 2_muertes_prematuras_enfermedades_notrasmisibles Assunto principal: Neoplasias da Mama / Receptor ErbB-2 Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google